Inogen | INGN - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Abbott USD 10.46B 1.15B 2026-06
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 143.94M 3.22M 2026-06
Baxter International USD 2.68B 3.36B 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Inogen USD 49.14M 665K 2024-09
Insulet USD 672M 32.3M 2026-06
Medtronic USD 7.92B 203M 2026-06
Orthofix International USD 213.79M 12.36M 2025-12
Philips EUR 3.75B 147M 2026-06
ResMed USD 1.01B 83.57M 2026-06
Steris USD 1.21B 62.8M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
X T L Biopharmaceuticals USD 1.1M 175K 2024-12
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06